Ritedose Expands U.S. Nebulized Drug Portfolio with FDA Approval
COLUMBIA, S.C., October 30, 2025 — The Ritedose Corporation has received U.S. Food and Drug Administration (FDA) approval to...
BFS technology
Advertisement
Apiject Submits First-of-Its-Kind Prefilled Injection Device for FDA Review
STAMFORD, CT, September 25, 2025 — Apiject Systems, Corp., a leading medical technology innovator, submitted its New Drug Application...
Advertisement
